Our Vision

A world where
every animal
can heal at home
with their family.

Stable recovery shouldn't mean a cage, a separation, or a bill a family can't meet.

We believe the best place to heal is at home — and that advanced care should be within reach of every animal, not just the ones whose families can afford the clinic stay.

Our Mission

To develop solutions
that enable better
and more affordable
healing at home.

We make continuous medication delivery simple enough to send home. Our ultra-portable, wearable CRI (Constant Rate Infusion) pump delivers the steady, controlled care once confined to the clinic — reducing cost, freeing up clinic capacity, and letting animals recover where they're most comfortable.

Evidence-Informed Recovery

Published veterinary studies suggest that hospital and clinic settings can increase stress-related physiologic and behavioral responses in dogs and cats.

Research also indicates that owner presence and low-stress handling can improve patient welfare.

While not every pet or procedure is appropriate for at-home recovery, the evidence supports home-based recovery as a meaningful welfare advantage for selected cases.

Evidence note: Direct randomized trials comparing full post-procedure recovery at home versus ICU for matched veterinary case types remain limited. Current evidence is strongest for hospital-associated stress, owner-separation effects, and the feasibility of selected home-based supportive care. Citations referenced at the bottom of this page.

Meet Our Team

Jeff Journey, MS

CEO

Executive operator and USAF Veteran with 30+ years experience across Fortune 100 and PE-backed engineered and regulated medical device and life science companies, such as J&J and Thermo Fisher Scientific.

Josh Alcorn

Head of Commercial

Growing up working in his father's vet clinic, Josh combines that formative experience along with 20+ years of leadership across sales and marketing, distribution, and strategy consulting.

Gary Knight

Technical Advisor

A Biomedical engineer with 40+ years designing and scaling innovative medical device solutions for both established (J&J) and early-stage companies.

Mark Bannister

Technical Advisor

As the Inventor of the RxActuator technology, Mark will continue to support the company under a fractional consulting agreement. He brings expertise in polymer physics, fluid mechanics, and medical device engineering.

John Corsale, DVM, MBA

Senior Veterinary Advisor

Veterinary Industry executive and respected leader with 25+ years of experience across Corporate, Clinical, and Academic Leadership. He was a Group Vice President at VCA (where he led 130 hospitals in the Southeast for 15 years) and the COO of Compassion First Pet Hospitals for 5 years (a PE-backed consolidator that started with 10 specialty hospitals, grew to 40, and was sold and merged into NVA/Ethos). 

Greg Blair, MBA

Industry Advisor

Global life sciences executive business development executive with over 30 years of experience across the Pharma, Med Tech and Animal Health sectors.  He has deep commercial expertise in strategic development, product launches and driving sales growth.  For over the past decade, Greg has been focused in the Animal Health sector with experiences across Animal Pharma, Medical Device and Diagnostics products.  

Clinical Advisory Board

Dr. Tyler Carmack, DVM

Clinical Advisor - Hospice and Palliative Care

DVM, CHPV, CVPP
Past President, the International
Association for Animal Hospice and Palliative Care (IAAHPC). Director of
Hospice and Palliative Care at Caring Pathways (national) and founder of
Hampton Roads Veterinary Hospice (2011), Certified Veterinary Pain Practitioner(CVPP) with deep expertise in multimodal pain management and at-home continuous care.

Dr. Lindsey Fry, DVM

Clinical Advisor - Pain Management

DVM, cVMA, CCRP, CVPP
Veterinarian/Owner, FryDay Veterinary
Mobility & Pain Management. Board Certified in Sports Medicine &
Rehabilitation. Pain practitioner, canine rehabilitation specialist, and
ketamine KOL. Early adopter, clinical champion, and frequent speaker of the efficacy of Ketamine for pain management.

Dr. James (Jamie) Gaynor, DVM

Clinical Advisor - Anesthesia

DVM, MS, DACVAA, DAIPM
Board-certified veterinary
anesthesiologist and pain management specialist. Former Section Chief,
Anesthesiology & Pain Management, Colorado State University. Certified
Veterinary Pain Practitioner.  Expert in
continuous-rate infusion and multimodal analgesia protocols across companion
animal species. First clinical adopter of the RxActuator Mini-Infuser®.

Dr. Mark Papich, DVM

Clinical Advisor - Pharmacology

DVM, PhD, DACVCP
Professor of Clinical Pharmacology and
Supervisor of the Clinical Pharmacology Laboratory at the College of Veterinary
Medicine at North Carolina State University.  Author of 8 veterinary pharmacology textbooks;
275+ peer-reviewed publications; 135+ book chapters. Led foundational PK
validation studies for the RxActuator Mini-Infuser.

Dr. Greg Staller, DVM

Clinical Advisor - Equine

DVM, DACVS
Owner and President, Running "S" Equine Veterinary Services. Board-certified veterinary surgeon with extensive equine surgical experience across sports medicine, ophthalmology, and internal medicine. Leads equine indication expansion for RxActuator.

Dr. Luke Wittenburg, DVM

Clinical Advisor - Oncology

DVM, PhD, DACVCP (Oncology)
Board-certified veterinary oncologist.
Professional of Developmental Cancer Therapeutics, University of
California-Davis.  Leads oncology
protocol development for RxActuator — metronomic chemotherapy, palliative analgesia,
and post-resection infusion.

Dr. Harry Cridge

Clinical Advisor - Internal Medicine

MVB, MS, PG Cert Vet Ed, DACVIM (SAIM), DECVIM-CA, FHEA, MRCVS.

Dr. Cridge is a board-certified small animal veterinary internal medicine specialist, educator, and researcher whose work focuses on advancing the diagnosis and management of gastrointestinal, pancreatic, and hepatobiliary diseases in dogs and cats. Leads companion animal internal medicine protocol development for RxActuator.

References

  1. Lloyd JKF. Minimising Stress for Patients in the Veterinary Hospital: Why It Is Important and What Can Be Done about It. Vet Sci. 2017.
  2. Väisänen MAM, et al. Pre-operative stress in dogs - a preliminary investigation of behavior and heart rate variability in healthy hospitalized dogs. Vet Anaesth Analg. 2005.
  3. Citron LE, et al. Urine cortisol-creatinine and protein-creatinine ratios in urine samples from healthy dogs collected at home and in hospital. 2020.
  4. Quimby JM, et al. Evaluation of the effects of hospital visit stress on physiologic parameters in the cat. J Feline Med Surg. 2011.
  5. Souza-Dantas LM, et al. Evaluation of clinical examination location on stress in cats: a randomized crossover trial. J Feline Med Surg. 2020.
  6. Klintip W, et al. First study on stress evaluation and reduction in hospitalized cats after neutering surgery. Vet World. 2022.
  7. Influence of hospital-induced stress on blood glucose concentrations, serum concentrations of cortisol, thyroxine and bile acids, and behaviour in cats. 2025.
  8. Lazard D, et al. Effect of dog-owner interaction on post-operative pain perception and stress of dogs and variability in their behavioural patterns. 2024.
  9. Dumont R, et al. Tolerability of naso-esophageal feeding tubes in dogs and cats at home: Retrospective review of 119 cases. J Vet Intern Med. 2023.
  10. Taylor S, et al. 2022 ISFM Consensus Guidelines on Management of the Inappetent Hospitalised Cat. J Feline Med Surg. 2022.